Medtide Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Public

  • Employees
  • 596

Employees

  • Stock Symbol
  • 03880

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.29
  • (As of Friday Closing)

Medtide General Information

Description

Medtide Inc offers full-cycle services ranging from early-stage discovery, preclinical research and clinical development to commercial-stage production. It mainly provide (i) CRO services, namely peptide NCE discovery synthesis; and (ii) CDMO services, namely peptide CMC development and commercial manufacturing. Its services focus on providing customers with APIs rather than drug products. Geographically, the company generates majority of its revenue from USA.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. 69
  • No. 12 Street, Qiantang District
  • Hangzhou, Zhejiang 310018
  • China
+86 0571
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
HKG
Corporate Office
  • No. 69
  • No. 12 Street, Qiantang District
  • Hangzhou, Zhejiang 310018
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medtide Stock Performance

As of 20-Nov-2026, Medtide’s stock price is $2.29. Its current market cap is $481M with 142M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.29 $2.37 $2.25 - $3.98 $481M 142M 96.5K $0.17

Medtide Financials Summary

As of 30-Jun-2026, Medtide has a trailing 12-month revenue of $78.7M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 443,251 402,214
Revenue 78,721 79,274 61,630 47,601
EBITDA 28,571 35,705 13,396 12,023
Net Income 24,159 30,227 8,247 6,912
Total Assets 274,580 259,063 160,632 184,627
Total Debt 4,493 4,395 5,636 45,544
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medtide Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medtide‘s full profile, request access.

Request a free trial

Medtide Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medtide Acquisitions (1)

Medtide’s most recent deal was a Merger/Acquisition with CPC Scientific for . The deal was made on 01-Jan-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CPC Scientific 01-Jan-2015 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Medtide’s complete acquisitions history, request access »

Medtide ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Medtide’s complete esg history, request access »

Medtide Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
CPC Scientific Rocklin, CA 2001

Medtide FAQs

  • When was Medtide founded?

    Medtide was founded in 2020.

  • Where is Medtide headquartered?

    Medtide is headquartered in Hangzhou, China.

  • What is the size of Medtide?

    Medtide has 596 total employees.

  • What industry is Medtide in?

    Medtide’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Medtide a private or public company?

    Medtide is a Public company.

  • What is Medtide’s stock symbol?

    The ticker symbol for Medtide is 03880.

  • What is the current stock price of Medtide?

    As of 20-Nov-2026 the stock price of Medtide is $2.29.

  • What is the current market cap of Medtide?

    The current market capitalization of Medtide is $481M.

  • What is Medtide’s current revenue?

    The trailing twelve month revenue for Medtide is $78.7M.

  • What is Medtide’s annual earnings per share (EPS)?

    Medtide’s EPS for 12 months was $0.17.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process